Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Tom Little"


25 mentions found


London CNN —Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. Additional measures to prevent obesity in the first place are desperately needed, health experts say. Part of that new thinking is exploring weight loss drugs. The OHA has crunched the numbers on existing weight loss drugs like Wegovy, the brand name for the appetite suppressant semaglutide. “There is no such thing as a silver bullet for obesity,” the Obesity Health Alliance emphasized.
Persons: Wes Streeting, Streeting, Eli Lilly, It’s, Keir Starmer, , Alfred Slade, suppressant, ” Slade, , it’s, Tom Little, prioritization, Jack Doughty, Martin White, ” White, White Organizations: London CNN, National Health Service, The Telegraph, Survey, British, Obesity Health Alliance, OHA, CNN, Reuters, Diabetes UK, NHS, of Health, Social Care, University of Cambridge Locations: United Kingdom, England, Novo Nordisk's, Denmark, sodas
Scientists grow mystery tree from 1,000-year-old seed
  + stars: | 2024-10-05 | by ( Katie Hunt | ) edition.cnn.com   time to read: +6 min
But it doesn’t mean that scientists aren’t interested in bringing the past back to life in some form. Dig thisThe tree, which the study authors believe may have a biblical connection, is seen at 12 years old. Remarkably, the tree thrived and now stands 10 feet (3 meters) tall, although it has never flowered or produced fruit. Using DNA sequencing, the researchers identified the mystery tree as part of the Commiphora genus, but its exact species is unknown and likely extinct. Scientists aim to extract DNA from the remains to learn more about those buried there and whether they were related.
Persons: — it’s, aren’t, Guy Eisner, Sarah Sallon, Louis, Tom Little, Alfred Nobel, didn’t, Johannes Fritz, , Ashley Strickland, Katie Hunt Organizations: CNN, Natural Medicine Research, Reuters Archaeologists, Vikings, International Union for Conservation of, NASA, , US Navy, — Marvel, CNN Space, Science Locations: , Judean, Jerusalem, India, Åsum, Denmark, Denmark’s, Swedish, Morocco, Europe, Austrian
CNN —Archaeologists in Denmark have unearthed more than 50 “exceptionally well preserved” skeletons in a large Viking-era burial ground in the east of the country. The skeletons were buried alongside artifacts from far beyond Denmark’s borders, suggesting Vikings traveled extensively for trade, according to the team from the museum. The conditions at the site are what helped keep the skeletons in such good shape, he said. “We had no clue that there was going to be a burial ground with Viking skeletons there,” Lundø said. A conservator at Museum Odense displays a brooch found in a Viking-age burial site during an interview with journalists in Odense, Denmark, September 25, 2024.
Persons: Michael Borre Lundø, , Tom Little, ” Lundø, Tom Little Tom Little, Reuters Lundø, , Åsum, Lundø, “ That’s Organizations: CNN, Archaeologists, Museum, Vikings, Reuters Archaeologists, Odense, REUTERS, Reuters Locations: Denmark, Museum Odense, Denmark’s, Åsum, Odense, Norway, Asum, Copenhagen, Danish
But health professionals are warning consumers not to take medical advice from the same companies trying to sell them food, supplements and other consumables. “People who are on (GLP-1 drugs) eat less calories. Daily Harvest, a meal kit service, has a GLP-1 food collection. In May it announced a new line of frozen meals called Vital Pursuit, pitching the brand to users of weight loss drugs. Some taking GLP-1 drugs have reported losing hair and muscle.
Persons: Ozempic, JP Morgan, , , Donny Kranson, GLP, Nestlé’s, Jorge Moreno, Jody Dushay, Tom Little, “ I’m, , 1nutrition.com, Atkins, Robert Atkins, Nestlé, Mark Schneider, Marie Callender’s, Slim Jim, Orville Redenbacher’s, Tom McGough, William Dietz Organizations: New, New York CNN, , Vontobel Asset Management, GNC, Nestlé, Visitors, Yale School of Medicine, Physicians, Harvard Medical School, Danone, Bloomberg, STOP, George Washington University Locations: New York, United States, Switzerland, Novo Nordisk's, Hillerod, Denmark, what’s, Conagra, GLP
Icelandic Volcano Calms Down but Risk Remains
  + stars: | 2024-01-16 | by ( Jan. | At A.M. | ) www.usnews.com   time to read: +1 min
Live video footage on Tuesday morning no longer showed signs of molten rock erupting from the ground, even as experts warned that new fissures could emerge at short notice. Grindavik resident Hrannar Jon Emilsson watched his almost-finished house burn down on live TV after the volcano erupted on Sunday. "You sit and watch the news showing everything go up in smoke," Emilsson told Icelandic independent broadcaster Channel 2. It was the second eruption on the peninsula of Reykjanes in four weeks, and the fifth since 2021. The Icelandic Civil Defence, the IMO and other experts are due to meet later on Tuesday to discuss the situation.
Persons: Hrannar Jon Emilsson, Emilsson, Gerhard Mey, Louise Breusch Rasmussen, Tom Little, Terje Solsvik, Bernadette Baum Organizations: Channel, Icelandic Meteorological, Icelandic Civil Defence Locations: REYKJAVIK, Iceland, Grindavik, Reykjanes, Reykjavik, Copenhagen
The logo of Danish drugmaker Novo Nordisk in their offices in Hillerod, Denmark, September 26, 2023. REUTERS/Tom Little Acquire Licensing RightsPARIS, Nov 23 (Reuters) - French President Emmanuel Macron will on Thursday inaugurate a 2.1 billion euro ($2.3 billion) investment by Danish pharmaceutical company Novo Nordisk (NOVOb.CO) in France, his office said, pitching it as a sign of newly restored French industrial competitiveness. The investment, for which no detail was provided by Macron's office, will be based in Chartres, west of Paris, where Novo already employs nearly 2,000 people. The Elysee palace deemed it the most significant investment in the health sector of Macron's mandates so far and said it would create 500 jobs. ($1 = 0.9168 euros)Reporting by Michel Rose, Editing by Dominique VidalonOur Standards: The Thomson Reuters Trust Principles.
Persons: Tom Little, Emmanuel Macron, Michel Rose, Dominique Vidalon Organizations: Novo Nordisk, REUTERS, Rights, Thomson Locations: Danish, Hillerod, Denmark, France, Chartres, Paris
By 2045 the government wants to have the equivalent of 10 new reactors, some of which are likely to be small modular reactors (SMRs), smaller than conventional reactors. Energy Minister Ebba Busch said the government was planning a "massive build out" of new nuclear power by 2045. "It's decisive for the green transition, for Swedish jobs and at heart for the welfare of our citizens," she told reporters. Countries like Poland, the Czech Republic, and Britain are looking at expanding nuclear power as societies transition to a fossil-fuel free future. Sweden voted to get rid of nuclear power in 1980, and has only six of an original 12 reactors still in production.
Persons: Tom Little, Ebba Busch, Elisabeth Svantesson, Busch, Finland's, Germany's Uniper, Simon Johnson, Chizu Nomiyama, Elaine Hardcastle Organizations: Rights, Energy, EDF, Thomson Locations: Swedish, Stockholm, Sweden, Rights STOCKHOLM, Poland, Czech Republic, Britain
Orsted's finance and operations chiefs out after big losses
  + stars: | 2023-11-14 | by ( ) www.reuters.com   time to read: +3 min
The offshore wind industry has found itself in a perfect storm of rising inflation, interest rate hikes and delays in the supply chain struggling to cope with growing demand. Orsted, the world's largest offshore wind developer, on Nov. 1 scrapped two U.S. offshore wind projects, flagging $5.6 billion in related impairments after delays, partly due to vessel availability, meant costs soared. "Together with the finance team and the group executive team, Rasmus Errboe will lead the work on supporting Orsted's capital structure and long-term commitment to its credit rating," the company said. Board member Andrew Brown, who has executive experience from Shell and Portugal's Galp, was appointed interim COO, Orsted said. The company said contracts it had signed for its U.S. offshore wind projects were secured recently and were therefore more reflective of current costs.
Persons: Tom Little, Rasmus Errboe, Andrew Brown, Daniel Lerup, Richard Hunter, Orsted, Mads Nipper, Nipper, Essi Lehto, Susanna Twidale, Louise Rasmussen, Mark Potter Organizations: REUTERS, Shell, RWE, Thomson Locations: Nysted, Denmark, HELSINKI
Orsted pulls out of Norway offshore wind consortium
  + stars: | 2023-11-13 | by ( ) www.reuters.com   time to read: +2 min
Earlier this month the Danish company, the world's largest offshore wind developer, also scrapped two U.S. offshore wind projects, flagging $5.6 billion in related impairments as costs ballooned due to rising interest rates and supply bottlenecks. Olsen Renewables AS, and Norwegian power producer Hafslund formed the Blaavinge consortium in 2021 to take part in planned offshore wind tenders in Norway. Olsen Seawind and Hafslund will not be able to participate in the bottom-fixed wind tender now that Orsted has pulled out of the consortium, Bonheur said. However, they still plan to work on a tender for floating offshore wind turbines. Norway has yet to announce the date for a floating offshore wind tender.
Persons: Tom Little, Orsted, Bonheur's, Olsen, Fred, Hafslund, Olsen Seawind, Bonheur, Nerijus Adomaitis, Susan Fenton Organizations: REUTERS, Rights, Bonheur ASA, Fred, Olsen Seawind ASA, Olsen Renewables AS, Thomson Locations: Nysted, Denmark, Rights OSLO, Norway, Danish, Norwegian
Risk of volcanic eruption in Iceland remains high
  + stars: | 2023-11-13 | by ( ) www.reuters.com   time to read: +3 min
COPENHAGEN, Nov 13 (Reuters) - Seismic activity in southwestern Iceland decreased in size and intensity on Monday, but the risk of a volcanic eruption remained significant, authorities said, after earthquakes and evidence of magma spreading underground in recent weeks. Thorvaldur Thordarson, professor in vulcanology at the University of Iceland, said most recent data indicated a smaller risk of an eruption in the area around the town of Grindavik. [1/5]A view of cracks, emerged on a road due to volcanic activity, near Grindavik, Iceland November 13, 2023. Volcanic activity in the area continued for six months that year, prompting thousands of Icelanders and tourists to visit the scene. In August 2022, a three-week eruption happened in the same area, followed by another in July of this year.
Persons: Matthew James Roberts, Thorvaldur Thordarson, Grindavik, Hans Vera, Vera, It's, Louise Rasmussen, Tom Little, Jacob Gronholt, Pedersen, Johannes Birkebaek, Ilze, Essi, Alex Richardson Organizations: Icelandic Meteorological, University of, Administration, Facebook, REUTERS Acquire, Thomson Locations: COPENHAGEN, Iceland, Reykjavik, vulcanology, University of Iceland, Grindavik, Belgian, Copenhagen, Stockholm, Helsinki
Fitch follows S&P in cutting Orsted's outlook
  + stars: | 2023-11-03 | by ( ) www.reuters.com   time to read: 1 min
A view of the turbines at Orsted's offshore wind farm near Nysted, Denmark, September 4, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsCompanies Orsted A/S FollowNov 3 (Reuters) - Rating agency Fitch on Friday downgraded the outlook on Danish renewable energy firm Orsted's (ORSTED.CO) rating to negative, a day after S&P warned of a possible debt downgrade due to the company's massive losses on projects in the United States. Fitch affirmed Orsted's Long-Term Issuer Default Rating (IDR) at 'BBB+'. The world's largest offshore wind developer on Wednesday said it had halted plans for two U.S. wind farms and that related impairments had surged above $5 billion, sending its share price down 26% to a six-year low. Reporting by Rishabh Jaiswal in Bengaluru Editing by Tomasz JanowskiOur Standards: The Thomson Reuters Trust Principles.
Persons: Tom Little, Fitch, Orsted's, Rishabh, Tomasz Janowski Organizations: REUTERS, Thomson Locations: Nysted, Denmark, United States, Bengaluru
Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsCOPENHAGEN, Nov 2 (Reuters) - Novo Nordisk (NOVOb.CO) on Thursday reported record sales and operating profits for the third quarter but said it would keep in place restrictions on supplies of its hugely popular Wegovy weight-loss drug. Wegovy sales totaled 9.6 billion Danish crowns ($1.36 billion) between July and September, up 28% from the previous quarter and up eight-fold from the same period last year. In August, Novo said the curbs on Wegovy supplies would most likely extend into 2024. Sales grew 29% year-on-year to 58.7 billion Danish crowns ($8.33 billion), while operating profit (EBIT) rose 33% to 26.9 billion, both in line with preliminary numbers released last month.
Persons: Tom Little, Wegovy, Novo, Eli Lilly, Jacob Gronholt, Pedersen, Terje Solsvik Organizations: Novo Nordisk, Danish, REUTERS, Rights, European Union, U.S . Food, Drug Administration, Thomson Locations: Copenhagen, Denmark, U.S, United States
A view of the turbines at Orsted's offshore wind farm near Nysted, Denmark, September 4, 2023. Orsted, the world's largest offshore wind developer, said in August it may see impairments of 16 billion Danish crowns ($2.3 billion) on its U.S. offshore developments due to supply chain problems, soaring interest rates and a lack of new tax credits. Norway's Equinor (EQNR.OL), BP's partner on those New York offshore wind developments, booked a $300 million impairment on the projects on Friday. In Massachusetts, two offshore wind developers, SouthCoast Wind and Commonwealth Wind, agreed to pay local utilities to terminate deals that would have delivered around 2,400 MW of energy. Avangrid also canceled a contract to sell power in Connecticut from its proposed 804-MW Park City offshore wind farm.
Persons: Tom Little, Denmark's, Joe Biden, Orsted, Jacob Pedersen, Portugal, France's, Avangrid, Scott DiSavino, Louise Breusch Rasmussen, Ron Bousso, Jonathan Oatis, Josie Kao Organizations: REUTERS, BP, U.S, Analysts, Reuters, Commonwealth, Shell, Energias, Thomson Locations: Nysted, Denmark, U.S, Danish, New York, Massachusetts, Connecticut, Rhode Island and Massachusetts, In Massachusetts, Commonwealth, Spanish, Copenhagen, London, Bengaluru
A view of the turbines at Orsted's offshore wind farm near Nysted, Denmark, September 4, 2023. The world's largest offshore wind farm developer has made a final investment decision on Revolution Wind, Orsted said in a statement, adding that it is expected to be completed by 2025. Development of the wind projects had been adversely affected by supply chain issues, increased interest rates and a lack of an OREC (offshore renewable energy certificate) adjustment on it's Sunrise Wind project, the company said. "Significant adverse developments from supply chain challenges, leading to delays in the project schedule, and rising interest rates have led us to this decision," Orsted chief executive officer Mads Nipper said. In August, Orsted said it may see U.S. impariments of $2.3 billion due to supply chain problems, soaring interest rates and a lack of new tax credits.
Persons: Tom Little, Orsted, Mads Nipper, Joe Biden, Gursimran Kaur, Christian Schmollinger, Michael Perry Organizations: REUTERS, U.S, Thomson Locations: Nysted, Denmark, Bengaluru
[1/4] A view of the turbines at an offshore wind farm near Nysted, Denmark, September 4, 2023. Time is short: The EU has a legally binding goal to nearly double renewable sources as a share of total energy by 2030, to 42.5%, requiring a rapid expansion of offshore wind. But of the governments surveyed, only Britain and Poland said they had invested or budgeted for steps to improve the security of offshore infrastructure. It requires a lot of effort from the government side," said Mattia Cecchinato, senior adviser for offshore wind at WindEurope. It said it would establish a permanent coast guard base close to where offshore wind farms are planned.
Persons: Tom Little, Thomas Almegaard, Vladimir Putin, Mads Nipper, Orsted, Ewa Skoog Haslum, James Appathurai, Germany's RWE, Anitta, Mattia Cecchinato, Rasmus, Krzysztof Jaworski, Orsted's Errboe, Benjamin Mallet, Riham, Elizabeth Piper, Toby Sterling, Andrius Sytas, Marek Strzelecki, Sara Ledwith Organizations: REUTERS, Reuters, Baltic Seas, EU, NATO, NewNew, Sweden's, Soaring, Emerging, Research, Solutions, Internal, Fund, Military, Naval Operations Centre, Polish Navy, Thomson Locations: Nysted, Denmark, Europe, Baltic, Nord, Finland, Sweden, Estonia, Russian, Russia, NewNew Shipping, Netherlands, Britain, Poland, Germany, North, Swedish, Copenhagen, Moscow, Sofia, European, Anitta Hipper, Belgium, Norway, France, Lithuania, Latvia, Baltic . Poland, Paris, Berlin, London, Amsterdam, Vilnius, Warsaw
REUTERS/Tom Little/File photo Acquire Licensing RightsSTOCKHOLM, Oct 26 (Reuters) - Swedish banking group Swedbank (SWEDa.ST) reported a bigger-than-expected third-quarter net profit on Thursday, and said the economy remained resilient despite turbulence and higher interest rates. Sweden's biggest mortgage lender posted a net profit of 9.13 billion crowns ($817 million), well above a forecast of 8.57 billion crowns in a LSEG poll of analysts. It had posted a profit of 5.59 billion crowns in the year-ago period. Swedbank, a rival to lenders such as Handelsbanken (SHBa.ST), Nordea (NDAFI.HE) and SEB (SEBa.ST), said interest income, which includes revenues from mortgages, rose to 12.9 billion crowns from 8.36 billion crowns a year ago, slightly beating expectations. Swedbank booked loan loss provisions of 347 million crowns, down from 602 million crowns in the year-ago quarter, and below analysts' expectations of losses of 583 million crowns.
Persons: Tom Little, Jens Henriksson, SEB, Swedbank, Johan Ahlander, Anna Ringstrom Organizations: REUTERS, Rights, Thomson Locations: Stockholm, Sweden, Rights STOCKHOLM, Swedish, Swedbank
Bank SEB's Q3 operating profit jumps 42%, beats expectations
  + stars: | 2023-10-25 | by ( ) www.reuters.com   time to read: +1 min
The Nordic bank SEB group logo is seen outside a branch in central Stockholm, Sweden, July 18, 2023. REUTERS/Tom Little Acquire Licensing RightsSTOCKHOLM, Oct 25 (Reuters) - Swedish bank SEB (SEBa.ST) reported a 42% rise in third-quarter operating profit on Wednesday, topping market expectations, but said the positive effect from higher interest rates had come down compared to previous quarters. Sweden's biggest corporate bank said operating profit was 13.0 billion crowns ($1.17 billion) against a year-ago 9.12 billion, beating a mean forecast of 11.0 billion in an LSEG poll of analysts. Banks have seen their income boosted by higher interest rates as central banks scrambled to bring down stubbornly high inflation. The bank, whose main rivals include Handelsbanken, Swedbank and Nordea, said its net interest income rose to 12.3 billion crowns from 7.7 billion crowns, above the 12.0 billion crowns expected by analysts.
Persons: Tom Little, SEBa.ST, Banks, SEB, Johan Ahlander, Anna Ringstrom, Eileen Soreng Organizations: REUTERS, Rights, Thomson Locations: Stockholm, Sweden, Rights STOCKHOLM, Swedish
Novo Nordisk in $1.3 bln deal to buy hypertension drug
  + stars: | 2023-10-16 | by ( ) www.reuters.com   time to read: +1 min
Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsCOPENHAGEN, Oct 16 (Reuters) - Novo Nordisk (NOVOb.CO) has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular and kidney disease, from KBP Biosciences for up to $1.3 billion, the Danish drugmaker said on Monday. "This deal is closely aligned with our strategic focus on expanding from our core in diabetes into other serious chronic diseases, including through novel drug modalities," Novo said in a statement. The acquisition is expected to close before the end of this year, Novo said, adding that the deal will not impact its operating profit outlook for 2023. Ocedurenone is an orally administered drug that is currently examined in the phase 3 trial CLARION-CKD in patients with uncontrolled hypertension and advanced chronic kidney disease, Novo said.
Persons: Tom Little, Danish drugmaker, Novo, Louise Breusch Rasmussen, Terje Solsvik Organizations: Novo Nordisk, Danish, REUTERS, Rights, KBP Biosciences, CLARION, Thomson Locations: Copenhagen, Denmark, Rights COPENHAGEN, Danish
Pens for the diabetes drug Ozempic sit on a production line at Danish drugmaker Novo Nordisk's site in Hillerod, Denmark, September 26, 2023. "Based on currently available clinical data and scientific evidence, Fresenius Medical Care assesses the overall effect of GLP-1 analog use on its own patient flow model as neutral," it said in a statement to Reuters. Novo said on Wednesday that the Ozempic trial was stopped ahead of schedule because independent supervisors had ruled the drug's positive effect on chronic kidney disease had become clear enough. In its statement, Fresenius Medical said that the early termination of the study, known as FLOW, does not allow for clear conclusions. Earlier on Thursday, rival DaVita (DVA.N) said that Novo's FLOW trial would only have a limited impact on overall dialysis patient numbers.
Persons: Tom Little, DaVita, Novo, Fresenius, Ludwig Burger, Jane Merriman, Kirsten Donovan Organizations: REUTERS, Rights, Novo Nordisk's, Reuters, Thomson Locations: Hillerod, Denmark
A view of the Balticconector pipeline as it is pulled into the sea in Paldiski, Estonia in an undated handout photo taken in 2019. ELERING/Handout via REUTERS/File Photo Acquire Licensing RightsVILNIUS/HELSINKI, Oct 11 (Reuters) - The damage to the Baltic Sea gas pipeline that burst on Sunday was caused by "quite heavy force", Estonian Defence Minister Hanno Pevkur said on Wednesday, a day after Finland said it could have been a deliberate action. The Balticconnector subsea gas pipeline and a telecommunications cable connecting Finland and Estonia were damaged on Sunday. On Tuesday, Helsinki said the damage was likely caused by "outside activity" and that the cause was being investigated. Location of damaged gas pipe"It can clearly be seen that these damages are caused by quite heavy force," Pevkur told Reuters, adding that investigators were not ruling out anything at this stage.
Persons: Hanno Pevkur, Pevkur, Henri Vanhanen, Andrius Sytas, Anne Kauranen, Tom Little, Gwladys Fouche, Terje Solsvik Organizations: REUTERS, Estonian Defence, Reuters, Finnish Institute for International Affairs, NATO, Thomson Locations: Paldiski, Estonia, Handout, VILNIUS, HELSINKI, Baltic, Finland, Helsinki, Vilnius, Malmo
Pens for the diabetes drug Ozempic sit on a production line to be packaged at Danish drugmaker Novo Nordisk's site in Hillerod, Denmark, September 26, 2023. Novo said the trial would be halted almost a year early based on a recommendation from the independent data monitoring board overseeing the study. Independent monitors can recommend stopping a trial early if there is clear evidence that a drug was going to succeed or fail based on interim analyses. Semaglutide is also the active ingredient in Novo Nordisk's powerful weight-loss drug Wegovy. Novo's success has also created an economic boom for Denmark, according to Danish economists, analysts, and executives at the Novo Nordisk Foundation.
Persons: Tom Little, Novo, Danish drugmaker, Wegovy, Emily Field, Patrick Wingrove, Sriparna Roy, Bill Berkrot Organizations: REUTERS, Novo Nordisk, Barclays, Novo Nordisk Foundation, Thomson Locations: Hillerod, Denmark, Danish, New York, Bengaluru
SummaryCompanies Women's rights campaigner serving 12 years' jailPrize likely to anger Iranian governmentNorwegian Nobel committee lauds Iranian protestersIranian news agency notes 'prize from westerners'OSLO, Oct 6 (Reuters) - Iran's imprisoned women's rights advocate Narges Mohammadi won the Nobel Peace Prize on Friday in a rebuke to Tehran's theocratic leaders and boost for anti-government protesters. "We want to give the prize to encourage Narges Mohammadi and the hundreds of thousands of people who have been crying for exactly 'Woman, Life, Freedom' in Iran," she added, referring to the protest movement's main slogan. She is the deputy head of the Defenders of Human Rights Center, a non-governmental organisation led by Shirin Ebadi, the 2003 Nobel Peace Prize laureate. [1/5]Iranian human rights activist and the vice president of the Defenders of Human Rights Center (DHRC) Narges Mohammadi poses in this undated handout picture. Among a stream of tributes from major global bodies, the U.N. human rights office said the Nobel award highlighted the bravery of Iranian women.
Persons: Narges Mohammadi, Berit Reiss, Andersen, Narges, Fars, Mohammadi, Shirin Ebadi, Maria Ressa, Russia's Dmitry Muratov, embolden Narges, Taghi Rahmani, Alfred Nobel, Martin Luther King, Nelson Mandela, Mohammadi's, Mahsa, We've, Elizabeth Throssell, They've, Hamidreza Mohammed, Dan Smith, Gwladys Fouche, Nerijus Adomaitis, Terje Solsvik, Tom Little, John Davison, Anthony Paone, Charlotte Van Campenhout, Gabrielle Tetrault, Farber, Cecile Mantovani, Andrew Cawthorne, William Maclean Organizations: Norwegian Nobel, Reuters, Defenders, of Human Rights, Philippines, REUTERS, New York Times, NRK, Stockholm International Peace Research Institute, Thomson Locations: Norwegian, OSLO, Iran, Tehran, Evin, Paris, Oslo, Iranian, Stockholm, Parisa, Dubai, Baghdad, Brussels, Geneva
Two members of the public walk into the Nobel Museum in Stockholm, Sweden, October 5, 2023. REUTERS/ Tom Little/ File Photo Acquire Licensing RightsOSLO, Oct 5 (Reuters) - Winning the Nobel prize for literature is both overwhelming and scary, Norwegian playwright and novelist Jon Fosse told Reuters following the announcement on Thursday. "I am overwhelmed, and somewhat frightened. I see this as an award to the literature that first and foremost aims to be literature, without other considerations," Fosse, who is also a poet, said in a statement. Reporting by Terje Solsvik, editing by Gwladys FoucheOur Standards: The Thomson Reuters Trust Principles.
Persons: Tom Little, Jon Fosse, Fosse, Terje Solsvik, Gwladys Organizations: Nobel Museum, REUTERS, Rights, Reuters, Thomson Locations: Stockholm, Sweden, Rights OSLO, Norwegian, Denmark
A general view of the Royal Swedish Academy of Sciences, where the Nobel Prize in Physics is to be announced, in Stockholm, Sweden October 3, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsSTOCKHOLM, Oct 4 (Reuters) - Sweden's Royal Academy of Sciences appeared to have inadvertently published names of three scientists it said had won this year's Nobel Prize in chemistry, although the award-giving institute said the decision was still hours away. But Johan Aqvist, chair of the academy's Nobel committee for chemistry, told Reuters: "It is a mistake by the Royal Swedish Academy of Sciences. The announcement of this year's Nobel prize for chemistry is due at 1145 CET (0945 GMT). The more than century-old prize is awarded by the Royal Swedish Academy of Sciences and is worth 11 million Swedish crowns ($990,019).
Persons: Tom Little, Moungi, Bawendi, Louis E . Brus, Alexei I, Johan Aqvist, Brus, Anna Ringstrom, Johan Ahlander, Terje Solsvik, Alex Richardson Organizations: Royal Swedish Academy of Sciences, REUTERS, Rights, Sweden's Royal Academy of Sciences, Dagens Nyheter, Reuters, Massachusetts Institute of Technology, Columbia University, Nanocrystals Technology Inc, Thomson Locations: Stockholm, Sweden, Rights STOCKHOLM
Flags with the Novo Nordisk logo flutter outside their Danish company's offices in Copenhagen, Denmark, September 26, 2023. The office's Patent Trial and Appeal Board denied the requests by Mylan Pharmaceuticals, which is owned by Viatris (VTRS.O), to review the validity of the Wegovy and Ozempic patents. A spokesperson for Novo Nordisk said the company will "vigorously defend" its intellectual property. Novo has filed several U.S. patent lawsuits against companies including Pennsylvania-based Viatris that are seeking to market generic versions of the drugs. Viatris has separately asked a West Virginia federal court to invalidate the patents as part of the litigation.
Persons: Tom Little, Wegovy, Ozempic, Mylan, Viatris, Novo's Wegovy, Novo, Blake Brittain, Patrick Wingrove, Will Dunham, David Bario Organizations: Novo Nordisk, Danish, REUTERS, Rights, U.S . Patent, Mylan Pharmaceuticals, Viatris, West, Thomson Locations: Copenhagen, Denmark, Pennsylvania, West Virginia, Washington, New York
Total: 25